MSB Trading - 2020, page-325

I don't have any science behind this, so it is just my observations & general intuition. Probably, nothing you don't already know

Here are my thoughts...

There are different investors in the market, its all about risks vs rewards & timeframe

Human behaviour used to play a bigger part, but now bots have skewed some of that

Bulls & bears, push SP beyond expectations, both ways, as experts play on these human emotions

Bots, play a part, but only ST. As, the valuation of the company comes out in the long run.

This is made worst for Biotech companies, like MSB, as valuations are not easy, as it is still a research company, but transitioning

So, then in the end each investor needs to make their own assessment

@bretto32, with gvhd, i don't think much convincing is required. Look at EAP & JCR experience. Just get FDA approval & then the product will sell itself = unmet medical need